E3

KRAS Has a New Contender. It Still Has to Earn Its Place.

Indigenous cardiovascular inequity is not a data gap. It is a policy failure

Menopause is a cardiometabolic checkpoint. Health systems still treat it like a hormone debate

China’s Biliary-Cancer Bet Has a Global Access Problem

GLP-1 drug choice now affects cardiovascular outcomes. Access and reimbursement rules have not caught up

A CE Mark Is Not Access

Pregnancy complications demand long-term cardiovascular care

MENA’s cardiometabolic crisis is a stability issue

The Transplant Is Not the Finish Line
Free IPM Alliance Newsletter
Insights on science, policy and access in personalised medicine.
